Table 4. Overall response rate in 22 patients included in efficacy analysis.
Objective Response Rate | Number of Patients, n (%) |
---|---|
Complete response | 0 |
Partial response | 4 (18) |
Stable disease > 6 months | 1 (4) |
Stable disease < 6 months | 9 (40) |
Progressive disease | 8 (36) |